European Testing Week media centre

In this section you will find European Testing Week newsletters, official press releases and statements from the European Testing Week Secretariat. 

You will also find factsheets for participants to populate with regional statistics in order to support media outreach activities. For guidance to help you with any media activities, you may wish to refer to Toolkit 2 – testing week implementation handbook available for download.



Read our 2018 newsletters informing participants and others of the latest news, updates and ongoing activities. You can also browse the newsletters from 2015 to 2017 to see what was achieved in previous years.


Press releases

To mark the start of European Testing Week (23-30 November 2018), the European Centre for Disease Prevention and Control has published their new public health guidance on integrated testing for HBV, HCV and HIV testing in the EU/EEA. The new guidance provides testing strategies based on the latest scientific evidence for national or local hepatitis B, C and HIV testing guidelines and programmes.  

The HIV in Europe and ETW initiatives have published a press release commending ECDC for recognising the importance of combined viral hepatitis and HIV testing efforts and calls upon the European community to implement the new guidance into national context and policies.


Statements from the European Testing Week Working Group



The ETW Secretariat recognises the struggles you have faced in adapting services in the new circumstances, with restrictions and people’s fear of catching Covid-19 while attending services.

During the Spring and Autumn ETW’s in 2020, our webinars and online videos highlighted a number of innovations you have developed including telemedicine, online services, self-testing, open air testing, integrated testing etc.

We encourage you to continue these great efforts.

To read our full statement, click here.

Past Statements



The ETW Secretariat recognises that many communities, especially those most marginalised, continue to struggle with closed, restricted and/or overloaded services due to the ongoing COVID-19 pandemic.

For the upcoming European Testing Week, we are committed to support your efforts to provide access to prevention, testing and care services for HIV, viral hepatitis and STIs, throughout the WHO European Region, however feasible in your organisation.

For those who can participate in the November 2020 ETW, we ask you to continue to advocate and raise awareness on the importance of HIV, viral hepatitis and STI services and share how your organisation is supporting your communities during this global pandemic.

To read our brief statement, please click the links below:

The November 2020 statement in English and Russian


The COVID-19 pandemic (caused by SARS-CoV-2) has profoundly affected the world and the situation continues to evolve day to day. Considering this, the Spring European Testing Week (SETW), planned for 15-22 May 2020, will proceed with a primarily focus on virtual-based SETW-related activities.

For SETW 2020, we encourage:

  • Sharing experiences from the HIV, viral hepatitis and sexually transmitted infection fields to work in unison against COVID-19.
  • Continuing to remind the European community that HIV, viral hepatitis and STI prevention, testing, care and support services are essential services and must continue to be supported, especially during times of crisis.

To read our full statement, click here



The theme of the November 2019 European Testing Week emphasises the importance of integrated testing of HIV, hepatitis B, hepatitis C, and sexually transmitted infections (when possible), as well as other related activities focused on increased awareness and access to testing and treatment, highlighting the importance of ETW’s longstanding tagline of Test.Treat.Prevent.

It is not a requirement to engage in integrated activities for #EuroTestWeek, however, ETW encourages all participants to use the week to create more awareness about the importance of testing for more than one condition (when possible). ETW recognises that legislative, financial and structural barriers may prohibit ETW participants in engaging in activities for other conditions, especially for conducting testing. However, ETW encourages the network to recognise the importance of integration and consider developing ways, big and small, to further inform target audiences about the importance of prevention, testing and treatment for HIV, viral hepatitis and STIs.

To read the theme statement, click here.


To commemorate the launch of Spring European Testing Week, the ETW Working Group has released a statement calling for the scale-up and prioritisation of testing for HIV, hepatitis B (HBV) and hepatitis C (HCV) in prisons and other closed settings.

There is a disproportionate burden of HIV, HBV and HCV in prisons and sub-optimal access to health care, therefore ETW highlights the importance of increasing testing efforts in prisons and other closed settings as part of a comprehensive package of health services.

To read the statement, click here.


The European Testing Week Working Group has released two statements supporting safer and voluntary testing for key and most affected populations for HIV and hepatitis. 

The first is a statement to all of Testing Week signatories to review the joint statement (available in 6 different languages) created by an informal alliance of NGOs and ensure access to effective, comprehensive, rights-based, safe, anonymous and voluntary HIV and Hepatitis testing for everyone in order to promote early diagnosis and linkage to care. 

The Working Group released a second statement that encourages government bodies and policy makers to review the joint statement and consider supporting the outlined principles in legislation.


OptTEST project: new searchable database

Want to know what legal and regulatory barriers your country, or others in Europe, are putting in the way of better HIV testing and treatment? Barring The Way To Health is a new searchable database which outlines a range of impediments to key populations and others with HIV who seek testing and access to care across the 53 countries of Europe and Central Asia. You can pull out a particular issue that concerns you across Europe, or read about a particular country. You can comment and offer amendments - and if your country is one of the small minority not yet covered, we welcome your information on it.

The OptTEST legal & regulatory barriers toolkit, is of use to anyone who wants to dismantle such barriers in their own country. The toolkit takes a "pick and mix" approach, enabling users to take what they need without wading through an enormous pdf. A series of case studies illustrates how activists, clinicians and other alliances took down specific barriers to HIV testing and treatment in their countries. Tip sheets show how to go about implementing these ideas, or your own, within your country setting. Slide sets will support presentations about the importance of identifying and mitigating barriers, to enable alliances and discussion. Each piece of the toolkit will be separately downloadable and the ideas within them adaptable to differing country circumstances and the original materials will be accompanied by a critical reading list which points the reader to many more existing resources online, with short explanations of their usefulness.



Factsheets are available to support your local media and partner engagement activities.